Ankit Mahadevia's Net Worth
$1.69 Million
Who is Ankit Mahadevia?
Ankit Mahadevia has an estimated net worth of $1.69 Million. This is based on reported shares in Spero Therapeutics, Inc..
SEC CIK
Ankit Mahadevia's CIK is 0001720974
Past Insider Trading and Trends
2020 was Ankit Mahadevia's most active year for acquiring shares with 13 total transactions. Ankit Mahadevia's most active month to acquire stocks was the month of January. 2020 was Ankit Mahadevia's most active year for disposing of shares, totalling 24 transactions. Ankit Mahadevia's most active month to dispose stocks was the month of June. 2020 saw Ankit Mahadevia paying a total of $265,500.00 for 225,000 shares, this is the most they've acquired in one year. In 2020 Ankit Mahadevia cashed out on 90,000 shares for a total of $644,098.52, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Spero Therapeutics, Inc. (SPRO) Snapshot price: $1.43
CEO and PresidentAnkit Mahadevia owns 744,997 units of Common Stock which is worth $1,065,345.71. From 2017 to 2024 Ankit Mahadevia acquired a total of 821,977 shares in Spero Therapeutics, Inc. at a cost of $340,288.40, Ankit also disposed a total of 142,797 shares of Spero Therapeutics, Inc. equalling to $964,228.86.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -7.89% | -63.80K |
$1.37 | -$87,399.15 | 745K |
Feb 2
| |||
Form 4
| +2.54% | 20K |
—
|
—
| 808.79K |
Oct 5
| |||
Form 4
| -1.13% | -9.04K |
$1.26 | -$11,390.40 | 788.79K |
Aug 28
| |||
Form 4
| -1.52% | -12.29K |
$1.81 | -$22,237.66 | 797.83K |
Feb 3
| |||
Form 4
| +191.20% | 531.91K |
—
|
—
| 810.12K |
Feb 1
| |||
Form 4
| +93.15% | 134.17K |
—
|
—
| 278.2K |
Feb 1
| |||
Form 4
|
—
|
0
|
$10.24 | -$69,466.40 | 144.04K |
Scheduled
|
Dec 27
| ||
Form 4
| +118.84% | 78.22K |
—
|
—
| 144.04K |
Aug 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
—
|
0
|
$10.15 | -$80,733.44 | 65.82K |
Scheduled
|
Nov 3 - Nov 4
| ||
Form 4
|
—
|
0
|
$10.07 | -$167.00 | 65.82K |
Scheduled
|
Oct 23
| ||
Form 4
|
—
|
0
|
$10.09 | -$121,323.93 | 65.82K |
Scheduled
|
Oct 13 - Oct 14
| ||
Form 4
|
—
|
0
|
$10.07 | -$6,463.13 | 65.82K |
Scheduled
|
Sep 8
| ||
Form 4
|
—
|
0
|
$10.09 | -$25,574.29 | 65.82K |
Scheduled
|
Jul 7 - Jul 9
| ||
Form 4
|
—
|
0
|
$10.10 | -$144,336.73 | 65.82K |
Scheduled
|
Jun 22 - Jun 25
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
$11.77 | -$54,848.33 | 65.82K |
Scheduled
|
Jul 5 - Jul 6
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||